DCEG - COVIDcode - Biospecimen support activities
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 75N91019D00024-P00003-759102000003-42
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$100,000Funder
National Institutes of Health (NIH)Principal Investigator
LEONARD FREEDMANResearch Location
United States of AmericaLead Research Institution
LEIDOS BIOMEDICAL RESEARCH, INC.Research Priority Alignment
N/A
Research Category
Health Systems Research
Research Subcategory
Medicines, vaccines & other technologies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Under this project, the contractor receives, processes, distributes and store biospecimens being collected from three distinct groups of COVID-19 positive patients (estimated study size is 5k). The contractor provides transport packaging and physical management of the shipping of the samples from the clinical sites to the bioprocessing laboratory. The contractor links the biospecimens received to biospecimen inventory system of record, processes and distributes those aliquots needed for immediate assay, while sending the excess to the NCI-Frederick Central Repository. Those samples may be retrieved for distribution based on DCEG requests and approvals. All samples will be handled according to CDC guidelines.